🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.123,91 USD

Máx. histórico

1.292,65

20 días

Split 2:1 del 16/10/1997

Caída desde máximo

-13,05%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-2,21%

Cierre anterior

1.149,36

Rango de hoy

1.113,55 – 1.134,53

Volumen hoy

2.274.262

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
37,75 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 6 horas
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,60%
Fecha de pago Importe por participación
08/02/1974 0,0147 USD
12/11/1973 0,0129 USD
13/08/1973 0,0129 USD
14/05/1973 0,0118 USD
09/02/1973 0,0118 USD
13/11/1972 0,0114 USD
07/08/1972 0,0114 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/05/1997 45,88 46,06 44,94 45,19 -1,77% 2,45% 2.459.600
05/05/1997 44,50 46,19 44,38 46,00 +4,10% 4,07% 2.562.200
02/05/1997 43,50 44,44 43,44 44,19 +2,17% 2,30% 2.325.200
01/05/1997 43,56 44,19 43,19 43,25 -1,56% 2,30% 1.945.200
30/04/1997 43,63 44,00 43,13 43,94 +0,29% 2,01% 2.429.600
29/04/1997 42,56 43,94 42,25 43,81 +4,32% 3,96% 2.136.000
28/04/1997 41,63 42,38 41,56 42,00 -0,30% 1,95% 1.721.200
25/04/1997 42,50 42,56 41,88 42,13 -1,61% 1,62% 1.299.600
24/04/1997 43,00 43,06 42,19 42,81 -0,29% 2,03% 1.771.600
23/04/1997 43,38 43,63 42,88 42,94 +1,03% 1,73% 1.677.000
22/04/1997 42,38 43,06 41,94 42,50 -0,15% 2,65% 2.654.400
21/04/1997 42,50 42,81 40,94 42,56 +0,15% 4,41% 4.375.400
18/04/1997 42,69 42,69 41,94 42,50 -0,44% 1,76% 1.512.000
17/04/1997 42,75 43,06 42,25 42,69 -1,16% 1,90% 2.139.200
16/04/1997 41,44 43,31 40,94 43,19 +3,29% 5,73% 1.864.200
15/04/1997 41,38 42,00 40,94 41,81 +3,56% 2,57% 2.823.400
14/04/1997 39,00 40,50 38,69 40,38 +3,36% 4,65% 2.160.800
11/04/1997 39,63 39,69 39,06 39,06 -1,73% 1,58% 2.491.400
10/04/1997 40,13 40,75 39,75 39,75 -0,47% 2,49% 5.178.200
09/04/1997 41,13 41,38 39,94 39,94 -3,18% 3,50% 3.410.800
08/04/1997 42,00 42,06 40,88 41,25 -1,93% 2,83% 3.364.000
07/04/1997 42,44 42,44 41,56 42,06 +0,90% 2,06% 2.453.000
04/04/1997 41,06 42,06 40,88 41,69 +0,45% 2,89% 3.427.600
03/04/1997 40,63 41,63 40,44 41,50 +2,00% 2,92% 2.081.600
02/04/1997 41,69 41,75 40,56 40,69 -2,98% 2,85% 2.593.200
01/04/1997 41,38 42,50 41,19 41,94 +1,98% 3,17% 4.561.800
31/03/1997 43,75 44,25 41,13 41,13 -6,27% 7,14% 3.381.600
27/03/1997 45,38 45,50 43,00 43,88 -3,17% 5,51% 3.268.000
26/03/1997 44,75 45,63 44,63 45,31 +1,54% 2,23% 3.216.800
25/03/1997 43,44 45,00 43,00 44,63 +2,88% 4,60% 3.501.200